These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6970636

  • 1. Mechanisms of immunity to leishmaniasis III. The development and decay of resistance during metastatic disease.
    Poulter LW, Pearce MT.
    Clin Exp Immunol; 1980 Nov; 42(2):211-8. PubMed ID: 6970636
    [Abstract] [Full Text] [Related]

  • 2. Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii.
    Bryceson AD, Bray RS, Dumonde DC.
    Clin Exp Immunol; 1974 Feb; 16(2):189-202. PubMed ID: 4619877
    [Abstract] [Full Text] [Related]

  • 3. Immunity in cutaneous leishmaniasis of the guinea-pig.
    Bryceson AD, Bray RS, Wolstencroft RA, Dumonde DC.
    Clin Exp Immunol; 1970 Sep; 7(3):301-41. PubMed ID: 4249071
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of immunity to leishmaniasis. I. Evidence for a changing basis of protection in self-limiting disease.
    Poulter LW.
    Clin Exp Immunol; 1980 Jan; 39(1):14-26. PubMed ID: 7389189
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY, Singleton A, Cillari E, Howard JG.
    J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
    [Abstract] [Full Text] [Related]

  • 6. Factors influencing the host response to Leishmania mexicana.
    Pérez H.
    Ciba Found Symp; 1983 Sep; 99():157-73. PubMed ID: 6227462
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of immunity to leishmaniasis. II. Significance of the intramacrophage localization of the parasite.
    Poulter LW.
    Clin Exp Immunol; 1980 Apr; 40(1):25-35. PubMed ID: 7389216
    [Abstract] [Full Text] [Related]

  • 8. Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide.
    Belehu A, Poulter LW, Turk JL.
    Clin Exp Immunol; 1976 Apr; 24(1):125-32. PubMed ID: 949870
    [Abstract] [Full Text] [Related]

  • 9. [Indices of the state of the T-system of immunity in experimental cutaneous leishmaniasis in guinea pigs].
    Konovalova SA.
    Med Parazitol (Mosk); 1981 Apr; 50(6):23-7. PubMed ID: 6976505
    [No Abstract] [Full Text] [Related]

  • 10. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY, Howard JG, Hale C.
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages.
    Mauel J, Behin R, Biroum-Noerjasin, Rowe DS.
    Clin Exp Immunol; 1975 May; 20(2):339-50. PubMed ID: 813928
    [Abstract] [Full Text] [Related]

  • 12. Resistance to cutaneous leishmaniasis: acquired ability of the host to kill parasites at the site of infection.
    Hill JO.
    Infect Immun; 1984 Jul; 45(1):127-32. PubMed ID: 6735464
    [Abstract] [Full Text] [Related]

  • 13. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P, Pearce E, Natovitz P, Sher A.
    J Immunol; 1987 Jul 01; 139(1):221-7. PubMed ID: 3495599
    [Abstract] [Full Text] [Related]

  • 14. The kinetics and quality of acquired resistance in self-healing and metastatic leishmaniasis.
    Poulter LW.
    Clin Exp Immunol; 1979 Apr 01; 36(1):30-7. PubMed ID: 380855
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. II. Selective destruction of different Leishmania species in activated guinea-pig and mouse macrophages.
    Behin R, Mauel J, Biroum-Noerjasin, Rowe DS.
    Clin Exp Immunol; 1975 May 01; 20(2):351-8. PubMed ID: 765014
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens.
    Behin R, Mauel J, Rowe DS.
    Clin Exp Immunol; 1977 Aug 01; 29(2):320-5. PubMed ID: 908177
    [Abstract] [Full Text] [Related]

  • 17. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG, Lima GC, Engers HD, Louis JA.
    J Immunol; 1984 Sep 01; 133(3):1594-600. PubMed ID: 6205088
    [Abstract] [Full Text] [Related]

  • 18. Protection against experimental toxoplasmosis by adoptive immunotherapy.
    Pavia CS.
    J Immunol; 1986 Nov 01; 137(9):2985-90. PubMed ID: 3489780
    [Abstract] [Full Text] [Related]

  • 19. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 20. Application of immunofluorescence to detection of antibody in Leishmania infections.
    Behforouz N, Rezai HR, Gettner S.
    Ann Trop Med Parasitol; 1976 Sep 15; 70(3):293-301. PubMed ID: 788659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.